Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Gilead sciences, inc. crawled date : 2021 - 06 - 04 save search
Kite's Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Earning Priority Review Designation
Published: 2021-06-04 (Crawled : 20:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
leukemia t-cell designation
Worldwide CAR-T Cell Therapy Industry - Featuring Aleta BioTherapeutics, Atara Biotherapeutics and BioNTech Among Others
Published: 2021-06-04 (Crawled : 16:00) - prnewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.28%
H: 0.38%
C: -0.06%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: 1.73%
H: 2.43%
C: -1.58%
PGEN | $1.33 0.76% 0.75% 1M
|
Health Technology
|
| O: 1.07%
H: 3.01%
C: 0.45%
PSTX | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -1.07%
H: 2.53%
C: 0.84%
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 2.46%
H: 8.41%
C: 6.91%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 1.53%
H: 9.81%
C: 6.61%
BLCM | $0.0748 381.28% 6.1K
|
Health Technology
|
| O: 0.0%
H: 2.74%
C: 0.68%
ANIX | $3.12 0.65% 0.64% 33K
|
Health Technology
|
| O: 1.78%
H: 6.25%
C: 3.0%
therapy car-t iot t-cell
List of Determinations Including Written Request
Published: 2021-06-04 (Crawled : 15:56) - fda.gov
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.79%
H: 0.55%
C: 0.19%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
Jounce Therapeutics Presents Trial in Progress Posters on the INNATE and SELECT Clinical Trials at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Published: 2021-06-04 (Crawled : 13:00) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 0.0%
H: 1.63%
C: -2.14%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
clinical trials trial
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Published: 2021-06-04 (Crawled : 12:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.47%
H: 1.17%
C: 0.96%
GLPG | News | $29.095 0.64% 0.64% 87K
|
Health Technology
|
| O: 0.1%
H: 1.07%
C: 0.0%
lancet ulcerative colitis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.